Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company. Kenvue shareholders will receive $3.50 per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback